These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 19026636)

  • 1. EF1A1-actin interactions alter mRNA stability to determine differential osteopontin expression in HepG2 and Hep3B cells.
    Zhang J; Guo H; Mi Z; Gao C; Bhattacharya S; Li J; Kuo PC
    Exp Cell Res; 2009 Jan; 315(2):304-12. PubMed ID: 19026636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA stability regulates differential expression of the metastasis protein, osteopontin, in hepatocellular cancer.
    Emani S; Zhang J; Guo L; Guo H; Kuo PC
    Surgery; 2008 Jun; 143(6):803-12. PubMed ID: 18549897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interference of osteopontin expression inhibits the invasion and metastasis of human hepatocellular carcinoma cell lines].
    Lin F; Li YY; Xia JT; Wen MJ; Lai YY; Cai WS; Wu ZF; Fan SF
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):422-5. PubMed ID: 19567019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells.
    Cheng J; Huo DH; Kuang DM; Yang J; Zheng L; Zhuang SM
    Cancer Res; 2007 Jun; 67(11):5141-7. PubMed ID: 17545592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Knocking down osteopontin expression by specific siRNA reduces the in vitro invasiveness of human hepatocellular carcinoma cells].
    Zhu XQ; Ye QH; Lei KF; Chen J; Qin LX
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):404-7. PubMed ID: 17152482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-induced transmembrane 3 binds osteopontin in vitro: expressed in vivo IFITM3 reduced OPN expression.
    El-Tanani MK; Jin D; Campbell FC; Johnston PG
    Oncogene; 2010 Feb; 29(5):752-62. PubMed ID: 19901966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor.
    Schultz J; Lorenz P; Ibrahim SM; Kundt G; Gross G; Kunz M
    Mol Carcinog; 2009 Jan; 48(1):14-23. PubMed ID: 18459127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin promotes hepatocellular carcinoma invasion by up-regulating MMP-2 and uPA expression.
    Chen RX; Xia YH; Xue TC; Ye SL
    Mol Biol Rep; 2011 Aug; 38(6):3671-7. PubMed ID: 21104439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A small interfering RNA targeting osteopontin as gastric cancer therapeutics.
    Gong M; Lu Z; Fang G; Bi J; Xue X
    Cancer Lett; 2008 Dec; 272(1):148-59. PubMed ID: 18694621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transactivation of human osteopontin promoter by human T-cell leukemia virus type 1-encoded Tax protein.
    Zhang J; Yamada O; Matsushita Y; Chagan-Yasutan H; Hattori T
    Leuk Res; 2010 Jun; 34(6):763-8. PubMed ID: 19767100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma.
    Zapf MA; Kothari AN; Weber CE; Arffa ML; Wai PY; Driver J; Gupta GN; Kuo PC; Mi Z
    Surgery; 2015 Oct; 158(4):1039-47; discussion 1047-8. PubMed ID: 26189955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-mediated suppression of apolipoprotein B mRNA translation requires the 5' UTR and is characterized by decreased binding of an insulin-sensitive 110-kDa 5' UTR RNA-binding protein.
    Sidiropoulos KG; Pontrelli L; Adeli K
    Biochemistry; 2005 Sep; 44(37):12572-81. PubMed ID: 16156669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer.
    Zhu Y; Denhardt DT; Cao H; Sutphin PD; Koong AC; Giaccia AJ; Le QT
    Oncogene; 2005 Sep; 24(43):6555-63. PubMed ID: 16007184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid hormone receptors suppress pituitary tumor transforming gene 1 activity in hepatoma.
    Chen RN; Huang YH; Yeh CT; Liao CH; Lin KH
    Cancer Res; 2008 Mar; 68(6):1697-706. PubMed ID: 18339849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA.
    Chen RX; Xia YH; Xue TC; Zhang H; Ye SL
    Oncol Rep; 2011 Mar; 25(3):803-8. PubMed ID: 21174062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin is involved in the formation of malignant pleural effusion in lung cancer.
    Cui R; Takahashi F; Ohashi R; Yoshioka M; Gu T; Tajima K; Unnoura T; Iwakami S; Hirama M; Ishiwata T; Iwase A; Takahashi K
    Lung Cancer; 2009 Mar; 63(3):368-74. PubMed ID: 18752867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis.
    Zhao J; Dong L; Lu B; Wu G; Xu D; Chen J; Li K; Tong X; Dai J; Yao S; Wu M; Guo Y
    Gastroenterology; 2008 Sep; 135(3):956-68. PubMed ID: 18555021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.
    Wai PY; Mi Z; Guo H; Sarraf-Yazdi S; Gao C; Wei J; Marroquin CE; Clary B; Kuo PC
    Carcinogenesis; 2005 Apr; 26(4):741-51. PubMed ID: 15661802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emodin inhibits the growth of hepatoma cells: finding the common anti-cancer pathway using Huh7, Hep3B, and HepG2 cells.
    Hsu CM; Hsu YA; Tsai Y; Shieh FK; Huang SH; Wan L; Tsai FJ
    Biochem Biophys Res Commun; 2010 Feb; 392(4):473-8. PubMed ID: 19895793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
    Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
    J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.